Motoneuronal mechanisms underlying age-related muscle weakness
Motoneuronal mechanisms underlying age-related muscle weakness
批准号:
10407020
负责人:
William David Arnold
金额:
$60.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-01 至 2026-03-31
关键词:
Action PotentialsAgeAge-MonthsAgingAnimalsCalcium-Activated Potassium ChannelCell membraneClinicalCommunitiesCross-Sectional StudiesDataDevelopmentDiseaseElderlyExhibitsExtensorFunctional disorderGoalsHumanImmunohistochemistryImpairmentIn SituIn VitroIncidenceInterventionIon ChannelKnowledgeLeadLegMeasuresMembraneMissionMolecularMotorMotor NeuronsMusMuscleMuscle FibersMuscle functionMuscular AtrophyNational Institute on AgingNeurologicPhysiologicalPlayPreparationPublic HealthResearchResearch DesignRisk FactorsRoleSensorySeriesSpinal CordTestingTimeTimeLineUnited States National Institutes of HealthUp-RegulationWestern BlottingWorkage relatedage-related muscle weaknessagedbasebiomarker developmentcohortearly detection biomarkersexperienceexperimental studyfrailtyhuman datahuman old age (65+)in vivomuscle formmuscle strengthneuromechanismphysically handicappedpreventprotein expressionsarcopeniasex
中文摘要
摘要
42%的老年人有一个或多个身体限制执行日常任务是必不可少的
在社区中保持独立。与肥胖相关的虚弱是身体
这是一个很大的障碍,因为虚弱使老年人的身体限制增加了4倍。几十年来,
与年龄相关的虚弱主要归因于肌肉质量的损失,但最近的数据表明,
起的作用比最初想象的要小,突出表明其他神经和/或肌肉质量相关
这些因素对弱点的发展至关重要。尽管保持体力的重要性,
随着年龄的增长,大多数研究都集中在保持肌肉质量上。所知甚少
关于可能导致年龄相关性虚弱的神经机制。这一知识空白
是开发新干预措施以增强老年人力量和功能的障碍。
在本申请中,我们将检验中心假设,即与年龄相关的虚弱部分是由于,
运动神经元(MN)SK通道(小电导钙激活钾通道),导致
固有MN兴奋性和放电率的依赖性降低。先前的研究表明,老化导致
MU(α-MN及其神经支配的肌纤维)数量减少,放电频率降低。然而,先前的工作
已经停止了确定是否年龄相关的减少MU数量与临床有关-
有意义的弱点,并确定离子机制的基础上减少MN的发射率老化。在
在本申请中,我们提出了一系列平行、横截面和纵向的动物(目的1和2),
人类实验(目标3)来检验我们的中心假设。目标1将确定MN兴奋性功能障碍是否是
参与与年龄相关的虚弱,并确定其与小鼠MU损失的时间关系。目标2将确定
老年小鼠MN兴奋性功能障碍的细胞机制。目标3将确定MN的作用
兴奋性和数量在临床上有意义的,年龄相关的弱点在老年人。这项工作符合
国家老龄化研究所(NIA)的目标。从这项工作中获得的知识有
有可能从根本上将肌肉减少症和虚弱研究领域转向MN兴奋性,
生物标志物的发展弱点,并确定关键的MN离子通道,可以作为一个
用于治疗或预防与年龄相关的虚弱的神经治疗靶点。
英文摘要
ABSTRACT
Forty-two percent of older adults have one or more physical limitations performing daily tasks that are essential
for maintaining independence in the community. Age-related weakness is an important contributor to physical
impairments, as weakness predisposes older adults to a 4-fold increase in physical limitations. For decades,
age-related weakness was largely attributed to the loss of muscle mass, but recent data indicates that mass
plays a lesser role than originally thought, highlighting that other neurological and/or muscle quality related
factors are critical in the development of weakness. Despite the significance of maintaining physical strength in
aging, the majority of the research has focused on maintaining muscle mass. Considerably less is known
regarding the neural mechanisms potentially contributing to age-related weakness. This knowledge gap
represents a barrier to the development of new interventions to enhance strength and function in older adults.
In this application we will test the central hypothesis that age-related weakness is due, in part, to upregulation in
motor neuron (MN) SK channels (small conductance calcium-activated potassium channels) that results in type-
dependent reductions in intrinsic MN excitability and firing rates. Prior work indicates that aging results in reduced
number of MUs (the α-MN and the muscle fibers that it innervates) and lower firing rates. However, prior work
has stopped short of determining whether age-related reductions in MU numbers are related to clinically-
meaningful weakness, and determining the ionic mechanisms underlying reduced MN firing rates in aging. In
this application we propose a series of parallel, cross-sectional and longitudinal animal (Aims 1 and 2) and
human experiments (Aim 3) to test our central hypothesis. Aim 1 will determine if MN excitability dysfunction is
involved in age-related weakness and determine its temporal relationship to MU loss in mice. Aim 2 will identify
the cellular mechanisms underlying MN excitability dysfunction in aged mice. Aim 3 will determine the role of MN
excitability and number in clinically-meaningful, age-related weakness in older adults. This work aligns with
stated goals from the National Institute on Aging (NIA). The knowledge to be gained from this work has the
potential to fundamentally shift the fields of sarcopenia and frailty research towards MN excitability as an early
biomarker for the development of weakness, and identifying key MN ion channels that could serve as a
neurotherapeutic targets for treating or preventing age-related weakness.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neural mechanisms of age-related weakness
-
批准号:10733022
-
项目类别:
-
资助金额:$65.05万
-
财政年份:2023
-
负责人:William David Arnold
-
依托单位:
Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography
-
批准号:10484558
-
项目类别:
-
资助金额:$88.94万
-
财政年份:2022
-
负责人:William David Arnold
-
依托单位:
Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography
-
批准号:10668482
-
项目类别:
-
资助金额:$81.3万
-
财政年份:2022
-
负责人:William David Arnold
-
依托单位:
Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography - Development of Regulatory Plans Supplement
-
批准号:10700526
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2022
-
负责人:William David Arnold
-
依托单位:
Motoneuronal mechanisms underlying age-related muscle weakness
-
批准号:10810941
-
项目类别:
-
资助金额:$11.87万
-
财政年份:2021
-
负责人:William David Arnold
-
依托单位:
Motoneuronal mechanisms underlying age-related muscle weakness
-
批准号:10612078
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2021
-
负责人:William David Arnold
-
依托单位:
Motoneuronal mechanisms underlying age-related muscle weakness
-
批准号:10618019
-
项目类别:
-
资助金额:$30.01万
-
财政年份:2021
-
负责人:William David Arnold
-
依托单位:
Motoneuronal mechanisms underlying age-related muscle weakness
-
批准号:10543345
-
项目类别:
-
资助金额:$11.87万
-
财政年份:2021
-
负责人:William David Arnold
-
依托单位:
Motoneuronal mechanisms underlying age-related muscle weakness
-
批准号:10641197
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2021
-
负责人:William David Arnold
-
依托单位:
Social Isolation and Loss of Physical Function: Defining a Novel Neuromuscular Phenotype
-
批准号:10057744
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2020
-
负责人:William David Arnold
-
依托单位:
Social Isolation and Loss of Physical Function: Defining a Novel Neuromuscular Phenotype
-
批准号:10263238
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2020
-
负责人:William David Arnold
-
依托单位:
Sarcopenia and the motor neuron
-
批准号:9326115
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2016
-
负责人:William David Arnold
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: